Beyond seizures: Comprehensive care approach for Lennox-Gastaut syndrome
Beyond seizures: A multidimensional approach to non-seizure issues in Lennox-Gastaut syndrome. Insights from Italian experts.
AI Summary
Lennox-Gastaut syndrome (LGS) is a severe form of epilepsy where non-seizure issues often matter more than seizure control itself. These include problems with cognition, behavior, sleep, movement, and daily living skills that significantly impact patients' quality of life. Rather than only counting seizures, clinicians need a comprehensive approach to assess how these broader issues affect patients throughout their lives. This research proposes a practical framework that healthcare teams can actually use in regular clinic visits to monitor these critical aspects of patient wellbeing.
The paper presents a clinic-ready assessment system that combines clinician observations with input from caregivers and teachers to create a more complete picture of patient health. The framework recommends regular conversations about non-seizure issues at every visit, with more formal assessments scheduled strategically—typically every 6-12 months for behavior and sleep, and annually for cognition and adaptive skills. Importantly, the approach personalizes care based on each patient's developmental stage, comorbidities, and family context rather than applying a one-size-fits-all approach.
Notably, the paper mentions emerging evidence that cannabidiol and fenfluramine may offer benefits beyond seizure reduction, potentially improving alertness, behavior, sleep, and communication in LGS patients. However, the authors emphasize that LGS-specific evidence for these treatments remains preliminary. The research agenda calls for better outcome assessment tools that capture meaningful changes and incorporate patient and caregiver perspectives, moving LGS care toward a focus on participation, resilience, and quality of life rather than seizure counts alone.
📄
Original Abstract
Related Research
Similar Studies
More Epilepsy research papers you might find interesting.
Review finds promise in acidic cannabinoids, but human benefits remain unproven
Long-term records link adjunctive CBD with fewer seizures in adults with LGS
Retrospective study links add-on CBD with sustained seizure reduction in…
Explore More Research
Stay informed about the latest cannabis science.